Background: The relationship between allergic disease and irritable bowel syndrome (IBS) is poorly understood. We aimed to investigate the potential association as well as the underlying immunological mechanisms. Methods: A retrospective case-control study of 108 atopic patients from among outpatients in an allergy clinic (allergic rhinitis [AR], n = 49; chronic urticaria [CU], n = 59) and 74 controls from among ward companions was conducted from November 2016 to March 2017. The detection rates and related gastrointestinal (GI) symptoms of IBS, as well as immunological indices, were calculated. Results: CU patients had a trend of increase in the detection of IBS compared to controls (OR = 4.846; 95% CI 0.967–24.279, p = 0.077). Loose stools (OR = 2.406; 95% CI 1.075–5.386, p < 0.05) and viscous stools (OR = 2.665; 95% CI 1.250–5.682, p < 0.05) were more common in CU patients. Atopic patients positive for serum total immunoglobulin E (IgE) (OR = 3.379; 95% CI 1.088–10.498, p < 0.05) or house dust mite (HDM)-specific IgE (OR = 3.640; 95% CI 1.228–10.790, p < 0.05) were more likely to have abdominal bloating. Besides, a positive association between levels of total IgE and severity of abdominal bloating was observed (p < 0.05). An HDM-specific IgE-positive reaction was independently associated with abdominal bloating in atopic patients (p < 0.05). Conclusions: Allergic disease has a clear clinical association with IBS with more frequent and severe symptoms of IBS. CU patients have a tendency to suffer from IBS, usually with diarrhea. Serum total IgE and HDM-specific IgE are positively correlated with GI symptoms in atopic patients.

Keywords:
Irritable bowel syndrome, Allergy, Urticaria, Rhinitis, Gastrointestinal symptoms, Immune reaction
1.
Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, Spiller R: Bowel disorders. Gastroenterology 2016; 150: 1393–1407.
2.
Long Y, Huang Z, Deng Y, Chu H, Zheng X, Yang J, Zhu Y, Fried M, Fox M, Dai N: Prevalence and risk factors for functional bowel disorders in South China: a population based study using the Rome III criteria. Neurogastroenterol Motil 2017; 29:e12897.
3.
Tobin MC, Moparty B, Farhadi A, DeMeo MT, Bansal PJ, Keshavarzian A: Atopic irritable bowel syndrome: a novel subgroup of irritable bowel syndrome with allergic manifestations. Ann Allergy Asthma Immunol 2008; 100: 49–53.
4.
Dunlop SP, Hebden J, Campbell E, Naesdal J, Olbe L, Perkins AC, Spiller RC: Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. Am J Gastroenterol 2006; 101: 1288–1294.
5.
Magnusson J, Lin XP, Dahlman-Hoglund A, Hanson LL, Telemo E, Magnusson O, Bengtsson U, Ahlstedt S: Seasonal intestinal inflammation in patients with birch pollen allergy. J Allergy Clin Immunol 2003; 112: 45–50.
6.
Tan TK, Chen AC, Lin CL, Shen TC, Li TC, Wei CC: Preschoolers with allergic diseases have an increased risk of irritable bowel syndrome when reaching school age. J Pediatr Gastroenterol Nutr 2017; 64: 26–30.
7.
Jones MP, Walker MM, Ford AC, Talley NJ: The overlap of atopy and functional gastrointestinal disorders among 23,471 patients in primary care. Aliment Pharmacol Ther 2014; 40: 382–391.
8.
Kaplan AP, Gimenez-Arnau AM, Saini SS: Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria. Allergy 2017; 72: 519–533.
9.
Eifan AO, Durham SR: Pathogenesis of rhinitis. Clin Exp Allergy 2016; 46: 1139–1151.
10.
Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, van Weel C, Agache I, Ait-Khaled N, Bachert C, Blaiss MS, Bonini S, Boulet LP, Bousquet PJ, Camargos P, Carlsen KH, Chen Y, Custovic A, Dahl R, Demoly P, Douagui H, Durham SR, van Wijk RG, Kalayci O, Kaliner MA, Kim YY, Kowalski ML, Kuna P, Le LT, Lemiere C, Li J, Lockey RF, Mavale-Manuel S, Meltzer EO, Mohammad Y, Mullol J, Naclerio R, O’Hehir RE, Ohta K, Ouedraogo S, Palkonen S, Papadopoulos N, Passalacqua G, Pawankar R, Popov TA, Rabe KF, Rosado-Pinto J, Scadding GK, Simons FE, Toskala E, Valovirta E, van Cauwenberge P, Wang DY, Wickman M, Yawn BP, Yorgancioglu A, Yusuf OM, Zar H, Annesi-Maesano I, Bateman ED, Ben Kheder A, Boakye DA, Bouchard J, Burney P, Busse WW, Chan-Yeung M, Chavannes NH, Chuchalin A, Dolen WK, Emuzyte R, Grouse L, Humbert M, Jackson C, Johnston SL, Keith PK, Kemp JP, Klossek JM, Larenas-Linnemann D, Lipworth B, Malo JL, Marshall GD, Naspitz C, Nekam K, Niggemann B, Nizankowska-Mogilnicka E, Okamoto Y, Orru MP, Potter P, Price D, Stoloff SW, Vandenplas O, Viegi G, Williams D: Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008; 63(suppl 86): 8–160.
11.
Saeki H, Furue M, Furukawa F, Hide M, Ohtsuki M, Katayama I, Sasaki R, Suto H, Takehara K: Guidelines for management of atopic dermatitis. J Dermatol 2009; 36: 563–577.
12.
Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica GW, Church MK, Ensina LF, Gimenez-Arnau A, Godse K, Goncalo M, Grattan C, Hebert J, Hide M, Kaplan A, Kapp A, Abdul Latiff AH, Mathelier-Fusade P, Metz M, Nast A, Saini SS, Sanchez-Borges M, Schmid-Grendelmeier P, Simons FE, Staubach P, Sussman G, Toubi E, Vena GA, Wedi B, Zhu XJ, Maurer M: The EAACI/GA(2) LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy 2014; 69: 868–887.
13.
Burney P, Malmberg E, Chinn S, Jarvis D, Luczynska C, Lai E: The distribution of total and specific serum IgE in the European Community Respiratory Health Survey. J Allergy Clin Immunol 1997; 99: 314–322.
14.
Caffarelli C, Deriu FM, Terzi V, Perrone F, De Angelis G, Atherton DJ: Gastrointestinal symptoms in patients with asthma. Arch Dis Child 2000; 82: 131–135.
15.
Caffarelli C, Cavagni G, Deriu FM, Zanotti P, Atherton DJ: Gastrointestinal symptoms in atopic eczema. Arch Dis Child 1998; 78: 230–234.
16.
Lillestol K, Helgeland L, Arslan Lied G, Florvaag E, Valeur J, Lind R, Berstad A: Indications of “atopic bowel” in patients with self-reported food hypersensitivity. Aliment Pharmacol Ther 2010; 31: 1112–1122.
17.
Walker MM, Powell N, Talley NJ: Atopy and the gastrointestinal tract – a review of a common association in unexplained gastrointestinal disease. Expert Rev Gastroenterol Hepatol 2014; 8: 289–299.
18.
Vara EJ, Svanes C, Skorge TD, Berstad A, Florvaag E, Jarvis D, Omenaas E, Waatevik M, Johannessen A, Lied GA: Functional Gastrointestinal Symptoms Are Associated with Higher Serum Total IgE Levels, but Less Atopic Sensitization. Dig Dis Sci 2016; 61: 189–197.
19.
Magen E, Chikovani T: Possible therapeutic role of IgE blockade in irritable bowel syndrome. World J Gastroenterol 2016; 22: 9451–9456.
20.
Gonzalez-Castro AM, Martinez C, Salvo-Romero E, Fortea M, Pardo-Camacho C, Perez-Berezo T, Alonso-Cotoner C, Santos J, Vicario M: Mucosal pathobiology and molecular signature of epithelial barrier dysfunction in the small intestine in irritable bowel syndrome. J Gastroenterol Hepatol 2017; 32: 53–63.
21.
Tam JS: Cutaneous manifestation of food allergy. Immunol Allergy Clin North Am 2017; 37: 217–231.
22.
Ipci K, Altintoprak N, Muluk NB, Senturk M, Cingi C: The possible mechanisms of the human microbiome in allergic diseases. Eur Arch Otorhinolaryngol 2017; 274: 617–626.
23.
Bisgaard H, Li N, Bonnelykke K, Chawes BL, Skov T, Paludan-Muller G, Stokholm J, Smith B, Krogfelt KA: Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. J Allergy Clin Immunol 2011; 128: 646–652.e641–e645.
24.
Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y: The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997; 159: 1739–1745.
25.
Minnei F, Wetzels C, De Hertogh G, Van Eyken P, Ectors N, Ambu R, Faa G, Kochuyt AM, Geboes K: Chronic urticaria is associated with mast cell infiltration in the gastroduodenal mucosa. Virchows Arch 2006; 448: 262–268.
26.
Dunlop S, Jenkins D, Spiller R: Distinctive Histological Patterns of Chronic Inflammatory Cells in Rectal Biopsies of Patients with Different Clinical Subtypes of IBS. Philadelphia, Saunders, 2002, p A316.
27.
Park JH, Rhee PL, Kim HS, Lee JH, Kim YH, Kim JJ, Rhee JC: Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome. J Gastroenterol Hepatol 2006; 21: 71–78.
28.
Lee H, Park JH, Park DI, Kim HJ, Cho YK, Sohn CI, Jeon WK, Kim BI, Chae SW: Mucosal mast cell count is associated with intestinal permeability in patients with diarrhea predominant irritable bowel syndrome. J Neurogastroenterol Motil 2013; 19: 244–250.
29.
Navines-Ferrer A, Serrano-Candelas E, Molina-Molina GJ, Martin M: IgE-related chronic diseases and anti-IgE-based treatments. J Immunol Res 2016; 2016: 8163803.
30.
Cingi C, Gevaert P, Mosges R, Rondon C, Hox V, Rudenko M, Muluk NB, Scadding G, Manole F, Hupin C, Fokkens WJ, Akdis C, Bachert C, Demoly P, Mullol J, Muraro A, Papadopoulos N, Pawankar R, Rombaux P, Toskala E, Kalogjera L, Prokopakis E, Hellings PW, Bousquet J: Multi-morbidities of allergic rhinitis in adults: European Academy of Allergy and Clinical Immunology Task Force Report. Clin Transl Allergy 2017; 7: 17.
31.
Benninger MS, Strohl M, Holy CE, Hanick AL, Bryson PC: Prevalence of atopic disease in patients with eosinophilic esophagitis. Int Forum Allergy Rhinol 2017; 7: 757–762.
32.
Park MI, Camilleri M: Is there a role of food allergy in irritable bowel syndrome and functional dyspepsia? A systematic review. Neurogastroenterol Motil 2006; 18: 595–607.
33.
Oehling A, Fernandez M, Cordoba H, Sanz ML: Skin manifestations and immunological parameters in childhood food allergy. J Investig Allergol Clin Immunol 1997; 7: 155–159.
34.
Malmberg LP, Saarinen KM, Pelkonen AS, Savilahti E, Makela MJ: Cow’s milk allergy as a predictor of bronchial hyperresponsiveness and airway inflammation at school age. Clin Exp Allergy 2010; 40: 1491–1497.
35.
Sanchez Caraballo JM, Cardona Villa R: Clinical and immunological changes of immunotherapy in patients with atopic dermatitis: randomized controlled trial. ISRN Allergy 2012; 2012: 183983.
36.
Fagan DL, Slaughter CA, Capra JD, Sullivan TJ: Monoclonal antibodies to immunoglobulin G4 induce histamine release from human basophils in vitro. J Allergy Clin Immunol 1982; 70: 399–404.
37.
Antico A, Pagani M, Vescovi PP, Bonadonna P, Senna G: Food-specific IgG4 lack diagnostic value in adult patients with chronic urticaria and other suspected allergy skin symptoms. Int Arch Allergy Immunol 2011; 155: 52–56.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.